Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Actinobaculum schaalii- invasive pathogen or innocent bystander? A retrospective observational study

Authors: Sarah Tschudin-Sutter, Reno Frei, Maja Weisser, Daniel Goldenberger, Andreas F Widmer

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Actinobaculum schaalii is a Gram-positive, facultative anaerobic coccoid rod, classified as a new genus in 1997. It grows slowly and therefore is easily overgrown by other pathogens, which are often found concomitantly. Since 1999, Actinobaculum schaalii is routinely investigated at our hospital, whenever its presence is suspected due to the detection of minute grey colonies on blood agar plates and negative reactions for catalase. The objective of this study was to determine the clinical significance of Actinobaculum schaalii, identified in our microbiology laboratory over the last 11 years.

Methods

All consecutive isolates with Actinobaculum schaalii were obtained from the computerized database of the clinical microbiology laboratory and patients whose cultures from any body site yielded this pathogen were analyzed. Observation of tiny colonies of Gram-positive, catalase-negative coccoid rods triggered molecular identification based on 16S rRNA gene sequencing.

Results

40 isolates were obtained from 27 patients during the last 11 years. The patient's median age was 81 (19-101) years, 25 (92.6%) had underlying diseases and 12 (44.4%) had a genitourinary tract pathology. Actinobaculum schaalii was isolated in 12 urine cultures, 21 blood cultures, and 7 deep tissue biopsies. Twenty-five (62.5%) specimens were monobacterial, the remaining 15 (37.5%) were polybacterial 7/7 deep tissue samples (three bloodcultures and five urine cultures). Recovery from urine was interpreted as colonization in 5 (18.6%) cases (41.6% of all urine samples). Six (22.2%) suffered from urinary tract infections, six (22.2%) from abscesses (skin, intraabdominal, genitourinary tract, and surgical site infections) and 10 (37.0%) from bacteremia.

Conclusions

In this largest case series so far, detection of Actinobaculum schaalii was associated with an infection - primarily sepsis and abscesses - in 81.5% of our patients. Since this pathogen is frequently part of polymicrobial cultures (42.5%) it is often overlooked or considered a contaminant. Detection of Actinobaculum schaalii in clinical isolates mainly reflects infection indicating that this Gram-positive rod is not an innocent bystander.
Literature
1.
go back to reference Lawson PA, Falsen E, Akervall E, Vandamme P, Collins MD: Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol. 1997, 47: 899-903. 10.1099/00207713-47-3-899.CrossRefPubMed Lawson PA, Falsen E, Akervall E, Vandamme P, Collins MD: Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol. 1997, 47: 899-903. 10.1099/00207713-47-3-899.CrossRefPubMed
2.
go back to reference Reinhard M, Prag J, Kemp M, Andresen K, Klemmensen B, Højlyng N, Sørensen SH, Christensen JJ: Ten cases of Actinobaculum schaalii infection: clinical relevance, bacterial identification, and antibiotic susceptibility. J Clin Microbiol. 2005, 43: 5305-8. 10.1128/JCM.43.10.5305-5308.2005.CrossRefPubMedPubMedCentral Reinhard M, Prag J, Kemp M, Andresen K, Klemmensen B, Højlyng N, Sørensen SH, Christensen JJ: Ten cases of Actinobaculum schaalii infection: clinical relevance, bacterial identification, and antibiotic susceptibility. J Clin Microbiol. 2005, 43: 5305-8. 10.1128/JCM.43.10.5305-5308.2005.CrossRefPubMedPubMedCentral
3.
go back to reference Bank S, Jensen A, Hansen TM, Søby KM, Prag J: Actinobaculum schaalii, a common uropathogen in elderly patients, Denmark. Emerg Infect Dis. 2010, 16: 76-80.CrossRefPubMedPubMedCentral Bank S, Jensen A, Hansen TM, Søby KM, Prag J: Actinobaculum schaalii, a common uropathogen in elderly patients, Denmark. Emerg Infect Dis. 2010, 16: 76-80.CrossRefPubMedPubMedCentral
4.
go back to reference Nielsen HL, Søby KM, Christensen JJ, Prag J: Actinobaculum schaalii: a common cause of urinary tract infection in the elderly population. Bacteriological and clinical characteristics. Scand J Infect Dis. 2010, 42: 43-7. 10.3109/00365540903289662.CrossRefPubMed Nielsen HL, Søby KM, Christensen JJ, Prag J: Actinobaculum schaalii: a common cause of urinary tract infection in the elderly population. Bacteriological and clinical characteristics. Scand J Infect Dis. 2010, 42: 43-7. 10.3109/00365540903289662.CrossRefPubMed
5.
go back to reference Fendukly F, Osterman B: Isolation of Actinobaculum schaalii and Actinobaculum urinale from a patient with chronic renal failure. J Clin Microbiol. 2005, 43: 3567-9. 10.1128/JCM.43.7.3567-3569.2005.CrossRefPubMedPubMedCentral Fendukly F, Osterman B: Isolation of Actinobaculum schaalii and Actinobaculum urinale from a patient with chronic renal failure. J Clin Microbiol. 2005, 43: 3567-9. 10.1128/JCM.43.7.3567-3569.2005.CrossRefPubMedPubMedCentral
6.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16: 128-40. 10.1016/0196-6553(88)90053-3.CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16: 128-40. 10.1016/0196-6553(88)90053-3.CrossRefPubMed
7.
go back to reference Wilson KH, Blichington RB, Greene RC: Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol. 1990, 28: 1942-6.PubMedPubMedCentral Wilson KH, Blichington RB, Greene RC: Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol. 1990, 28: 1942-6.PubMedPubMedCentral
8.
go back to reference Drancourt M, Berger P, Raoult D: Systematic 16S rRNA. Gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol. 2004, 42: 2197-202. 10.1128/JCM.42.5.2197-2202.2004.CrossRefPubMedPubMedCentral Drancourt M, Berger P, Raoult D: Systematic 16S rRNA. Gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol. 2004, 42: 2197-202. 10.1128/JCM.42.5.2197-2202.2004.CrossRefPubMedPubMedCentral
9.
go back to reference Bosshard P, Abels S, Zbinden R, Böttger EC, Altwegg M: Ribosomal DNA sequencing for identification of aerobic gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol. 2003, 41: 4134-40. 10.1128/JCM.41.9.4134-4140.2003.CrossRefPubMedPubMedCentral Bosshard P, Abels S, Zbinden R, Böttger EC, Altwegg M: Ribosomal DNA sequencing for identification of aerobic gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol. 2003, 41: 4134-40. 10.1128/JCM.41.9.4134-4140.2003.CrossRefPubMedPubMedCentral
10.
go back to reference Beguelin C, Genne D, Vara A, Tritten ML, Siegrist HH, Jaton K, Lienhard R: Actinobaculum schaalii: clinical observation of 20 cases. Clin Microbiol Infect. 2010, Beguelin C, Genne D, Vara A, Tritten ML, Siegrist HH, Jaton K, Lienhard R: Actinobaculum schaalii: clinical observation of 20 cases. Clin Microbiol Infect. 2010,
11.
go back to reference Cattoir V, Varca A, Greub G, Prod'hom G, Legrand P, Lienhard R: In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance. J Antimicrob Chemother. 2010, 65: 2514-7. 10.1093/jac/dkq383.CrossRefPubMed Cattoir V, Varca A, Greub G, Prod'hom G, Legrand P, Lienhard R: In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance. J Antimicrob Chemother. 2010, 65: 2514-7. 10.1093/jac/dkq383.CrossRefPubMed
12.
go back to reference Haller P, Bruderer T, Schaeren S, Laifer G, Frei R, Battegay M, Flückiger U, Bassetti S: Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen. Eur J Clin Microbiol Infect Dis. 2007, 26: 667-70. 10.1007/s10096-007-0345-x.CrossRefPubMed Haller P, Bruderer T, Schaeren S, Laifer G, Frei R, Battegay M, Flückiger U, Bassetti S: Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen. Eur J Clin Microbiol Infect Dis. 2007, 26: 667-70. 10.1007/s10096-007-0345-x.CrossRefPubMed
13.
go back to reference Hoenigl M, Leitner E, Valentin T, Zarfel G, Salzer HJ, Krause R, Grisold AJ: Endocarditis caused by Actinobaculum schaalii, Austria. Emerg Infect Dis. 2010, 16: 1171-3.CrossRefPubMed Hoenigl M, Leitner E, Valentin T, Zarfel G, Salzer HJ, Krause R, Grisold AJ: Endocarditis caused by Actinobaculum schaalii, Austria. Emerg Infect Dis. 2010, 16: 1171-3.CrossRefPubMed
Metadata
Title
Actinobaculum schaalii- invasive pathogen or innocent bystander? A retrospective observational study
Authors
Sarah Tschudin-Sutter
Reno Frei
Maja Weisser
Daniel Goldenberger
Andreas F Widmer
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-289

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.